We are live on ! Find out more
CELU icon

Celularity

28 hedge funds and large institutions have $2.89M invested in Celularity in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,217% more call options, than puts

Call options by funds: $237K | Put options by funds: $18K

279% more capital inflows, than outflows

Capital inflows: $116K | Capital outflows: $30.7K

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

8% more funds holding

Funds holding: 26 → 28 (+2)

0.09% more ownership

Funds ownership: 4.34% → 4.43% (+0.09%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
6
Closed
2
Calls
$237​K
Puts
$18​K
Net Calls
+$219​K
Net Calls Change
+$124​K

CELU Hedge Fund Activity: Q3 2024 in Review

28 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2024, worth a combined $2.89M — down 2.2% from $2.96M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CELU positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $37.1K. The largest seller was Geode Capital Management, cutting an estimated $12K.

  • 28 institutional investors held Celularity (CELU) as of Q3 2024, up from 26 in Q2 2024.
  • Funds reported $2.89M of Celularity stock for Q3 2024, down 2.2% quarter-over-quarter.
  • 4 funds opened new Celularity positions in Q3 2024 and 2 closed out, a net change of +2 holders.
  • The largest Celularity buyer in Q3 2024 was BlackRock, an estimated $37.1K added.
  • The largest Celularity seller in Q3 2024 was Geode Capital Management, an estimated $12K sold.

Based on aggregated 13F filings for Q3 2024.